4 studies found for:    vabicaserin
Show Display Options
Rank Status Study
1 Completed Study Comparing Bioavailability of Oral Formulations of Vabicaserin
Condition: Schizophrenia
Intervention: Drug: vabicaserin
2 Completed
Has Results
Study Evaluating Vabicaserin in Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: vabicaserin;   Drug: risperidone;   Other: placebo
3 Completed Comparative Formulation Study of Vabicaserin
Condition: Healthy Subjects
Intervention: Drug: vabicaserin
4 Withdrawn Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SCA-136 50mg/day;   Drug: SCA-136 150 mg/day;   Drug: SCA-136 300mg/day;   Drug: Risperidone 4mg/day

Indicates status has not been verified in more than two years